Ligand Pharmaceuticals Incorporated (LGNXZ)
OTCMKTS · Delayed Price · Currency is USD
0.0015
0.00 (0.00%)
At close: Aug 29, 2025
Ligand Pharmaceuticals Market Cap
Ligand Pharmaceuticals has a market cap or net worth of $3.27 billion as of September 5, 2025. Its market cap has increased by 71.43% in one year.
Market Cap
3.27B
Enterprise Value
3.03B
Revenue
187.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 25, 1994, Ligand Pharmaceuticals's market cap has increased from 76.19M to 3.27B, an increase of 4,188.92%. That is a compound annual growth rate of 12.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 3.27B | 61.40% |
| Dec 31, 2024 | 2.02B | 62.59% |
| Dec 29, 2023 | 1.25B | 10.35% |
| Dec 30, 2022 | 1.13B | -56.28% |
| Dec 31, 2021 | 2.58B | 61.40% |
| Dec 31, 2020 | 1.60B | -12.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 840.66M |
| Elite Pharmaceuticals | 757.64M |
| Tian'an Technology Group | 660.01M |
| Glass House Brands | 561.06M |
| Northwest Biotherapeutics | 393.37M |
| CytoDyn | 391.17M |
| American Oncology Network | 361.55M |